AngioDynamics, Inc. (ANGO) is set to release its first-quarter earnings before the market opens on Thursday, October 3. Analysts anticipate a loss of 15 cents per share, compared to a loss of 12 cents per share in the same period last year. The company is also projected to report revenue of $67.93 million. Recent analyst ratings and price targets suggest a positive outlook for AngioDynamics, with several analysts reiterating Buy or Outperform ratings.